AVTRAvantor, Inc.

Healthcare

$15.67+25% 1Y

$15.67

$7.4152 weeks$15.85

Is it safe?

Mixed

Solid, nothing alarming: clean books, but big price swings.

1 good, 1 to watch, 3 neutral, 1 without data

SurvivalGrey zone

Mixed, watch the balance sheet Altman Z-score, a bankruptcy-risk model from five balance-sheet ratios.

Honest booksLow risk

Reported earnings show no manipulation flags Beneish M-score, a forensic model that detects earnings-manipulation patterns (receivables outrunning sales, margins slipping, accrual-heavy profit).

Quality4 / 9

Mixed fundamental signals Piotroski F-score, nine pass/fail tests of year-over-year financial health across profitability, balance sheet and efficiency. 7 to 9 is strong, 0 to 3 weak.

Credit gradeAderived · Mar 31, 2026

Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.

Drawdown risk48% volderived · Oct 9, 2026

Large price swings, high volatility. Worst drawdown -83% · now at/near its 52-week high.

Unless marked, from SEC EDGAR, as of Dec 31, 2025.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Volatilitymiddle of the market

Max drawdownbehind 79% of the market

Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.

Can AVTR take a bad year?

Avantor, Inc. carries $3.54B of net debt at 29.1× EBITDA: a heavy load to carry through a bad year.

$3.54B

Net debt · as at Q1 2026 · over four years of earnings before interest, tax and depreciation, heavy

Net debt / EBITDA: 29.1×
Net debt / EBITDA · 2.54× a year ago · the load is going up
Altman Z-score: 1.46
Altman Z-score · distress zone, below 1.8
Debt / equity: 0.68×
Debt / equity